4//SEC Filing
BG Medicine, Inc. 4
Accession 0001181431-15-008835
CIK 0001407038operating
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 4:46 PM ET
Size
49.5 KB
Accession
0001181431-15-008835
Insider Transaction Report
Form 4
AFEYAN NOUBAR
Director10% Owner
Transactions
- Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,756 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−32$73→ 58,232 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-12-15→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−3,256→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-07-28→ Common Stock (3,256 underlying) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+3,256$456→ 57,010 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−206$468→ 56,804 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,042 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,280 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,534 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+508$71→ 58,264 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,518 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-09-28→ Common Stock (254 underlying) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,058 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,296 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,772 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-09-08→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-11-14→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−508→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2016-03-10→ Common Stock (508 underlying)
Holdings
- 43,930
Common Stock
- 441,072(indirect: Held by Flagship Ventures Fund 2007, L.P.)
Common Stock
- 2,508(indirect: Held by Atlast LP)
Common Stock
- 786,970(indirect: Held by Applied Genomic Technology Capital Fund, L.P.)
Common Stock
Flagship Pioneering, LLC
10% Owner
Transactions
- Sale
Common Stock
2015-07-27$2.27/sh−206$468→ 56,804 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,042 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,280 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+3,256$456→ 57,010 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,058 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,518 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−32$73→ 58,232 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,296 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+508$71→ 58,264 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,534 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−3,256→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-07-28→ Common Stock (3,256 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-09-28→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-12-15→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−508→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2016-03-10→ Common Stock (508 underlying) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,772 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,756 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-09-08→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-11-14→ Common Stock (254 underlying)
Holdings
- 2,508(indirect: Held by Atlast LP)
Common Stock
- 43,930
Common Stock
- 786,970(indirect: Held by Applied Genomic Technology Capital Fund, L.P.)
Common Stock
- 441,072(indirect: Held by Flagship Ventures Fund 2007, L.P.)
Common Stock
NewcoGen Group, Inc.
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+3,256$456→ 57,010 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,518 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−32$73→ 58,232 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-11-14→ Common Stock (254 underlying) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,756 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−206$468→ 56,804 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,058 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,280 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,534 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+508$71→ 58,264 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−3,256→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-07-28→ Common Stock (3,256 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-09-28→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-12-15→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−508→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2016-03-10→ Common Stock (508 underlying) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,042 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,296 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,772 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-09-08→ Common Stock (254 underlying)
Holdings
- 441,072(indirect: Held by Flagship Ventures Fund 2007, L.P.)
Common Stock
- 786,970(indirect: Held by Applied Genomic Technology Capital Fund, L.P.)
Common Stock
- 43,930
Common Stock
- 2,508(indirect: Held by Atlast LP)
Common Stock
AGTC ADVISORS FUND LP
10% Owner
Transactions
- Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+508$71→ 58,264 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-09-28→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−508→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2016-03-10→ Common Stock (508 underlying) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,772 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−32$73→ 58,232 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,756 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-09-08→ Common Stock (254 underlying) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,042 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,296 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,534 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-12-15→ Common Stock (254 underlying) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,058 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−3,256→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-07-28→ Common Stock (3,256 underlying) - Sale
Common Stock
2015-07-27$2.27/sh−206$468→ 56,804 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,518 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-11-14→ Common Stock (254 underlying) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+3,256$456→ 57,010 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,280 total(indirect: Held by AGTC Advisors Fund, L.P.)
Holdings
- 43,930
Common Stock
- 2,508(indirect: Held by Atlast LP)
Common Stock
- 786,970(indirect: Held by Applied Genomic Technology Capital Fund, L.P.)
Common Stock
- 441,072(indirect: Held by Flagship Ventures Fund 2007, L.P.)
Common Stock
AGTC Partners, L.P.
10% Owner
Transactions
- Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,518 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−206$468→ 56,804 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,296 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,772 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−508→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2016-03-10→ Common Stock (508 underlying) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,042 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,534 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-12-15→ Common Stock (254 underlying) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,756 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+3,256$456→ 57,010 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+254$36→ 57,058 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−32$73→ 58,232 total(indirect: Held by AGTC Advisors Fund, L.P.) - Sale
Common Stock
2015-07-27$2.27/sh−16$36→ 57,280 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Common Stock
2015-07-27$0.14/sh+508$71→ 58,264 total(indirect: Held by AGTC Advisors Fund, L.P.) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−3,256→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-07-28→ Common Stock (3,256 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-09-08→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-09-28→ Common Stock (254 underlying) - Exercise of In-Money
Warrant to Purchase Common Stock (right to buy)
2015-07-27−254→ 0 total(indirect: Held by AGTC Advisors Fund, L.P.)Exercise: $0.14Exp: 2015-11-14→ Common Stock (254 underlying)
Holdings
- 786,970(indirect: Held by Applied Genomic Technology Capital Fund, L.P.)
Common Stock
- 2,508(indirect: Held by Atlast LP)
Common Stock
- 43,930
Common Stock
- 441,072(indirect: Held by Flagship Ventures Fund 2007, L.P.)
Common Stock
Footnotes (12)
- [F1]Share and price per share amounts have been adjusted to reflect a 1-for-4 reverse split of the Issuer's common stock on July 8, 2015.
- [F10]Noubar B. Afeyan, Ph.D. is the general partner of Atlast LP and may be deemed to beneficially own the securities held by Atlast LP. Dr. Afeyan disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F11]Noubar B. Afeyan, Ph.D. and Edwin M. Kania, Jr. are managers of Flagship Ventures 2007 General Partner LLC, which is the general partner of Flagship Ventures Fund 2007, L.P., and may be deemed to beneficially own the securities held by Flagship Ventures Fund 2007, L.P. Each of Dr. Afeyan and Mr. Kania disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F12]This warrant is immediately exercisable.
- [F2]On July 27, 2015, AGTC Advisors Fund, L.P. ("AGTCA") exercised warrants to purchase 3,256 shares of Common Stock for $0.14 per share. AGTCA exercised the warrants on a cashless basis, resulting in the Issuer's withholding of 206 of the warrant shares to pay the exercise price and issuing to AGTCA the remaining 3,050 shares.
- [F3]NewcoGen Group, Inc. ("NG") is the general partner of AGTC Partners, L.P., which is the general partner of AGTCA and Applied Genomic Technology Capital Fund, L.P. ("AGTCF", and together with AGTCA, the "AGTC Funds"). NG is a wholly-owned subsidiary of Flagship Ventures Management, Inc. ("Flagship"). Noubar B. Afeyan, Ph.D. is the director of Flagship and may be deemed to beneficially own the securities held by the AGTC Funds. Dr. Afeyan disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
- [F4]The price reflects the average of the closing prices of the Common Stock over the five day period prior to the exercise date.
- [F5]On July 27, 2015, AGTCA exercised warrants to purchase 254 shares of Common Stock for $0.14 per share. AGTCA exercised the warrants on a cashless basis, resulting in the Issuer's withholding of 16 of the warrant shares to pay the exercise price and issuing to AGTCA the remaining 238 shares.
- [F6]On July 27, 2015, AGTCA exercised warrants to purchase 254 shares of Common Stock for $0.14 per share. AGTCA exercised the warrants on a cashless basis, resulting in the Issuer's withholding of 16 of the warrant shares to pay the exercise price and issuing to AGTCA the remaining 238 shares.
- [F7]On July 27, 2015, AGTCA exercised warrants to purchase 254 shares of Common Stock for $0.14 per share. AGTCA exercised the warrants on a cashless basis, resulting in the Issuer's withholding of 16 of the warrant shares to pay the exercise price and issuing to AGTCA the remaining 238 shares.
- [F8]On July 27, 2015, AGTCA exercised warrants to purchase 254 shares of Common Stock for $0.14 per share. AGTCA exercised the warrants on a cashless basis, resulting in the Issuer's withholding of 16 of the warrant shares to pay the exercise price and issuing to AGTCA the remaining 238 shares.
- [F9]On July 27, 2015, AGTCA exercised warrants to purchase 508 shares of Common Stock for $0.14 per share. AGTCA exercised the warrants on a cashless basis, resulting in the Issuer's withholding of 32 of the warrant shares to pay the exercise price and issuing to AGTCA the remaining 476 shares.
Documents
Issuer
BG Medicine, Inc.
CIK 0001407038
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001407038
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 4:46 PM ET
- Size
- 49.5 KB